Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada.
Identifieur interne : 000238 ( Main/Exploration ); précédent : 000237; suivant : 000239Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada.
Auteurs : Aynslie M. Hinds [Canada] ; Songul Bozat-Emre [Canada] ; Paul Van Caeseele [Canada] ; Salaheddin M. Mahmud [Canada]Source :
- BMC public health [ 1471-2458 ] ; 2015.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Caractéristiques de l'habitat (MeSH), Enfant (MeSH), Enfant d'âge préscolaire (MeSH), Facteurs socioéconomiques (MeSH), Femelle (MeSH), Grippe humaine (épidémiologie), Hospitalisation (statistiques et données numériques), Humains (MeSH), Incidence (MeSH), Jeune adulte (MeSH), Manitoba (épidémiologie), Mâle (MeSH), Nourrisson (MeSH), Nouveau-né (MeSH), Répartition par âge (MeSH), Services de santé (statistiques et données numériques), Sujet âgé (MeSH), Vaccins antigrippaux (administration et posologie), Virus de la grippe A (MeSH), Virus influenza B (MeSH), Épidémies de maladies (MeSH), État de santé (MeSH).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- statistiques et données numériques : Hospitalisation, Services de santé.
- épidémiologie : Grippe humaine, Manitoba.
- Adolescent, Adulte, Adulte d'âge moyen, Caractéristiques de l'habitat, Enfant, Enfant d'âge préscolaire, Facteurs socioéconomiques, Femelle, Humains, Incidence, Jeune adulte, Mâle, Nourrisson, Nouveau-né, Répartition par âge, Sujet âgé, Virus de la grippe A, Virus influenza B, Épidémies de maladies, État de santé.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Age Distribution (MeSH), Aged (MeSH), Child (MeSH), Child, Preschool (MeSH), Disease Outbreaks (MeSH), Female (MeSH), Health Services (statistics & numerical data), Health Status (MeSH), Hospitalization (statistics & numerical data), Humans (MeSH), Incidence (MeSH), Infant (MeSH), Infant, Newborn (MeSH), Influenza A virus (MeSH), Influenza B virus (MeSH), Influenza Vaccines (administration & dosage), Influenza, Human (epidemiology), Male (MeSH), Manitoba (epidemiology), Middle Aged (MeSH), Residence Characteristics (MeSH), Socioeconomic Factors (MeSH), Young Adult (MeSH).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- epidemiology : Influenza, Human, Manitoba.
- statistics & numerical data : Health Services, Hospitalization.
- Adolescent, Adult, Age Distribution, Aged, Child, Child, Preschool, Disease Outbreaks, Female, Health Status, Humans, Incidence, Infant, Infant, Newborn, Influenza A virus, Influenza B virus, Male, Middle Aged, Residence Characteristics, Socioeconomic Factors, Young Adult.
Abstract
BACKGROUND
Despite the public health significance of annual influenza outbreaks, the literature comparing the epidemiology of influenza A and B infections is limited and dated and may not reflect recent trends. In Canada, the relative contribution of influenza A and B to the burden of morbidity is not well understood. We examined rates of laboratory-confirmed cases of influenza A and B (LCI-A and LCI-B) in the Canadian province of Manitoba between 1993 and 2008 and compared cases of the two types in terms of socio-demographic and clinical characteristics.
METHODS
Laboratory-confirmed cases of influenza A and B in Manitoba between 1993 and 2008 were identified from the Cadham Provincial Laboratory (CPL) Database and linked to de-identified provincial administrative health records. Crude and age-adjusted incidence rates of LCI-A and LCI-B were calculated. Demographic characteristics, health status, health service use, and vaccination history were compared by influenza type.
RESULTS
Over the study period, 1,404 of LCI-A and 445 cases of LCI-B were diagnosed, corresponding to an annual age-standardized rate of 7.2 (95% CI: 6.5-7.9) for LCI-A and 2.2 (CI: 1.5 - 3.0) per 100,000 person-years for LCI-B. Annual rates fluctuated widely but there was less variation in the LCI-B rates. For LCI-A, but not LCI-B, incidence was inversely related to household income. Older age, urban residence and past hospitalization were associated with increased detection of LCI-A whereas receipt of the influenza vaccine was associated with decreased LCI-A detection. Once socio-demographic variables were controlled, having a pre-existing chronic disease or immune suppression was not related to influenza type.
CONCLUSION
Influenza A and B affected different segments of the population. Older age was associated with increased LCI-A detection, but not with pre-existing chronic diseases. This information may be useful to public health professionals in planning and evaluating new and existing seasonal influenza vaccines.
DOI: 10.1186/s12889-015-1351-z
PubMed: 25633280
PubMed Central: PMC4331145
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada.</title><author><name sortKey="Hinds, Aynslie M" sort="Hinds, Aynslie M" uniqKey="Hinds A" first="Aynslie M" last="Hinds">Aynslie M. Hinds</name><affiliation wicri:level="4"><nlm:affiliation>Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, S111 - 750 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0W3, Canada. umhinds0@myumanitoba.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, S111 - 750 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0W3</wicri:regionArea><orgName type="university">Université du Manitoba</orgName><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Bozat Emre, Songul" sort="Bozat Emre, Songul" uniqKey="Bozat Emre S" first="Songul" last="Bozat-Emre">Songul Bozat-Emre</name><affiliation wicri:level="4"><nlm:affiliation>Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, S111 - 750 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0W3, Canada. songul.bozat-emre@gov.mb.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, S111 - 750 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0W3</wicri:regionArea><orgName type="university">Université du Manitoba</orgName><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Van Caeseele, Paul" sort="Van Caeseele, Paul" uniqKey="Van Caeseele P" first="Paul" last="Van Caeseele">Paul Van Caeseele</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Microbiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. Paul.Vancaeseele@gov.mb.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Medical Microbiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba</wicri:regionArea><orgName type="university">Université du Manitoba</orgName><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation><affiliation wicri:level="1"><nlm:affiliation>Cadham Provincial Laboratory, Winnipeg, Manitoba, Canada. Paul.Vancaeseele@gov.mb.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Cadham Provincial Laboratory, Winnipeg, Manitoba</wicri:regionArea><wicri:noRegion>Manitoba</wicri:noRegion></affiliation></author><author><name sortKey="Mahmud, Salaheddin M" sort="Mahmud, Salaheddin M" uniqKey="Mahmud S" first="Salaheddin M" last="Mahmud">Salaheddin M. Mahmud</name><affiliation wicri:level="4"><nlm:affiliation>Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, S111 - 750 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0W3, Canada. Salah.mahmud@gmail.com.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, S111 - 750 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0W3</wicri:regionArea><orgName type="university">Université du Manitoba</orgName><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation><affiliation wicri:level="4"><nlm:affiliation>Faculty of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada. Salah.mahmud@gmail.com.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Faculty of Pharmacy, University of Manitoba, Winnipeg, Manitoba</wicri:regionArea><orgName type="university">Université du Manitoba</orgName><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25633280</idno><idno type="pmid">25633280</idno><idno type="doi">10.1186/s12889-015-1351-z</idno><idno type="pmc">PMC4331145</idno><idno type="wicri:Area/Main/Corpus">000237</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000237</idno><idno type="wicri:Area/Main/Curation">000237</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000237</idno><idno type="wicri:Area/Main/Exploration">000237</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada.</title><author><name sortKey="Hinds, Aynslie M" sort="Hinds, Aynslie M" uniqKey="Hinds A" first="Aynslie M" last="Hinds">Aynslie M. Hinds</name><affiliation wicri:level="4"><nlm:affiliation>Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, S111 - 750 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0W3, Canada. umhinds0@myumanitoba.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, S111 - 750 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0W3</wicri:regionArea><orgName type="university">Université du Manitoba</orgName><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Bozat Emre, Songul" sort="Bozat Emre, Songul" uniqKey="Bozat Emre S" first="Songul" last="Bozat-Emre">Songul Bozat-Emre</name><affiliation wicri:level="4"><nlm:affiliation>Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, S111 - 750 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0W3, Canada. songul.bozat-emre@gov.mb.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, S111 - 750 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0W3</wicri:regionArea><orgName type="university">Université du Manitoba</orgName><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Van Caeseele, Paul" sort="Van Caeseele, Paul" uniqKey="Van Caeseele P" first="Paul" last="Van Caeseele">Paul Van Caeseele</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Microbiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. Paul.Vancaeseele@gov.mb.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Medical Microbiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba</wicri:regionArea><orgName type="university">Université du Manitoba</orgName><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation><affiliation wicri:level="1"><nlm:affiliation>Cadham Provincial Laboratory, Winnipeg, Manitoba, Canada. Paul.Vancaeseele@gov.mb.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Cadham Provincial Laboratory, Winnipeg, Manitoba</wicri:regionArea><wicri:noRegion>Manitoba</wicri:noRegion></affiliation></author><author><name sortKey="Mahmud, Salaheddin M" sort="Mahmud, Salaheddin M" uniqKey="Mahmud S" first="Salaheddin M" last="Mahmud">Salaheddin M. Mahmud</name><affiliation wicri:level="4"><nlm:affiliation>Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, S111 - 750 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0W3, Canada. Salah.mahmud@gmail.com.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, S111 - 750 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0W3</wicri:regionArea><orgName type="university">Université du Manitoba</orgName><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation><affiliation wicri:level="4"><nlm:affiliation>Faculty of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada. Salah.mahmud@gmail.com.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Faculty of Pharmacy, University of Manitoba, Winnipeg, Manitoba</wicri:regionArea><orgName type="university">Université du Manitoba</orgName><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author></analytic><series><title level="j">BMC public health</title><idno type="eISSN">1471-2458</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Age Distribution (MeSH)</term><term>Aged (MeSH)</term><term>Child (MeSH)</term><term>Child, Preschool (MeSH)</term><term>Disease Outbreaks (MeSH)</term><term>Female (MeSH)</term><term>Health Services (statistics & numerical data)</term><term>Health Status (MeSH)</term><term>Hospitalization (statistics & numerical data)</term><term>Humans (MeSH)</term><term>Incidence (MeSH)</term><term>Infant (MeSH)</term><term>Infant, Newborn (MeSH)</term><term>Influenza A virus (MeSH)</term><term>Influenza B virus (MeSH)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (epidemiology)</term><term>Male (MeSH)</term><term>Manitoba (epidemiology)</term><term>Middle Aged (MeSH)</term><term>Residence Characteristics (MeSH)</term><term>Socioeconomic Factors (MeSH)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Caractéristiques de l'habitat (MeSH)</term><term>Enfant (MeSH)</term><term>Enfant d'âge préscolaire (MeSH)</term><term>Facteurs socioéconomiques (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (épidémiologie)</term><term>Hospitalisation (statistiques et données numériques)</term><term>Humains (MeSH)</term><term>Incidence (MeSH)</term><term>Jeune adulte (MeSH)</term><term>Manitoba (épidémiologie)</term><term>Mâle (MeSH)</term><term>Nourrisson (MeSH)</term><term>Nouveau-né (MeSH)</term><term>Répartition par âge (MeSH)</term><term>Services de santé (statistiques et données numériques)</term><term>Sujet âgé (MeSH)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Virus de la grippe A (MeSH)</term><term>Virus influenza B (MeSH)</term><term>Épidémies de maladies (MeSH)</term><term>État de santé (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term><term>Manitoba</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Health Services</term><term>Hospitalization</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Hospitalisation</term><term>Services de santé</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term><term>Manitoba</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Distribution</term><term>Aged</term><term>Child</term><term>Child, Preschool</term><term>Disease Outbreaks</term><term>Female</term><term>Health Status</term><term>Humans</term><term>Incidence</term><term>Infant</term><term>Infant, Newborn</term><term>Influenza A virus</term><term>Influenza B virus</term><term>Male</term><term>Middle Aged</term><term>Residence Characteristics</term><term>Socioeconomic Factors</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Caractéristiques de l'habitat</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Facteurs socioéconomiques</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Jeune adulte</term><term>Mâle</term><term>Nourrisson</term><term>Nouveau-né</term><term>Répartition par âge</term><term>Sujet âgé</term><term>Virus de la grippe A</term><term>Virus influenza B</term><term>Épidémies de maladies</term><term>État de santé</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Despite the public health significance of annual influenza outbreaks, the literature comparing the epidemiology of influenza A and B infections is limited and dated and may not reflect recent trends. In Canada, the relative contribution of influenza A and B to the burden of morbidity is not well understood. We examined rates of laboratory-confirmed cases of influenza A and B (LCI-A and LCI-B) in the Canadian province of Manitoba between 1993 and 2008 and compared cases of the two types in terms of socio-demographic and clinical characteristics.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Laboratory-confirmed cases of influenza A and B in Manitoba between 1993 and 2008 were identified from the Cadham Provincial Laboratory (CPL) Database and linked to de-identified provincial administrative health records. Crude and age-adjusted incidence rates of LCI-A and LCI-B were calculated. Demographic characteristics, health status, health service use, and vaccination history were compared by influenza type.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Over the study period, 1,404 of LCI-A and 445 cases of LCI-B were diagnosed, corresponding to an annual age-standardized rate of 7.2 (95% CI: 6.5-7.9) for LCI-A and 2.2 (CI: 1.5 - 3.0) per 100,000 person-years for LCI-B. Annual rates fluctuated widely but there was less variation in the LCI-B rates. For LCI-A, but not LCI-B, incidence was inversely related to household income. Older age, urban residence and past hospitalization were associated with increased detection of LCI-A whereas receipt of the influenza vaccine was associated with decreased LCI-A detection. Once socio-demographic variables were controlled, having a pre-existing chronic disease or immune suppression was not related to influenza type.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>Influenza A and B affected different segments of the population. Older age was associated with increased LCI-A detection, but not with pre-existing chronic diseases. This information may be useful to public health professionals in planning and evaluating new and existing seasonal influenza vaccines.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">25633280</PMID><DateCompleted><Year>2015</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2015</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada.</ArticleTitle><Pagination><MedlinePgn>35</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-015-1351-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite the public health significance of annual influenza outbreaks, the literature comparing the epidemiology of influenza A and B infections is limited and dated and may not reflect recent trends. In Canada, the relative contribution of influenza A and B to the burden of morbidity is not well understood. We examined rates of laboratory-confirmed cases of influenza A and B (LCI-A and LCI-B) in the Canadian province of Manitoba between 1993 and 2008 and compared cases of the two types in terms of socio-demographic and clinical characteristics.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Laboratory-confirmed cases of influenza A and B in Manitoba between 1993 and 2008 were identified from the Cadham Provincial Laboratory (CPL) Database and linked to de-identified provincial administrative health records. Crude and age-adjusted incidence rates of LCI-A and LCI-B were calculated. Demographic characteristics, health status, health service use, and vaccination history were compared by influenza type.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Over the study period, 1,404 of LCI-A and 445 cases of LCI-B were diagnosed, corresponding to an annual age-standardized rate of 7.2 (95% CI: 6.5-7.9) for LCI-A and 2.2 (CI: 1.5 - 3.0) per 100,000 person-years for LCI-B. Annual rates fluctuated widely but there was less variation in the LCI-B rates. For LCI-A, but not LCI-B, incidence was inversely related to household income. Older age, urban residence and past hospitalization were associated with increased detection of LCI-A whereas receipt of the influenza vaccine was associated with decreased LCI-A detection. Once socio-demographic variables were controlled, having a pre-existing chronic disease or immune suppression was not related to influenza type.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Influenza A and B affected different segments of the population. Older age was associated with increased LCI-A detection, but not with pre-existing chronic diseases. This information may be useful to public health professionals in planning and evaluating new and existing seasonal influenza vaccines.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hinds</LastName><ForeName>Aynslie M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, S111 - 750 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0W3, Canada. umhinds0@myumanitoba.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozat-Emre</LastName><ForeName>Songul</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, S111 - 750 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0W3, Canada. songul.bozat-emre@gov.mb.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Caeseele</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. Paul.Vancaeseele@gov.mb.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cadham Provincial Laboratory, Winnipeg, Manitoba, Canada. Paul.Vancaeseele@gov.mb.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahmud</LastName><ForeName>Salaheddin M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, S111 - 750 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0W3, Canada. Salah.mahmud@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada. Salah.mahmud@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006296" MajorTopicYN="N">Health Services</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="Y">Influenza A virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009981" MajorTopicYN="Y">Influenza B virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008350" MajorTopicYN="N">Manitoba</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012111" MajorTopicYN="N">Residence Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>08</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>01</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25633280</ArticleId><ArticleId IdType="doi">10.1186/s12889-015-1351-z</ArticleId><ArticleId IdType="pii">s12889-015-1351-z</ArticleId><ArticleId IdType="pmc">PMC4331145</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vaccine. 2011 Sep 2;29(38):6558-63</Citation><ArticleIdList><ArticleId IdType="pubmed">21767593</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2010 Feb 23;182(3):257-64</Citation><ArticleIdList><ArticleId IdType="pubmed">20093297</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2009 Jan 15;199(2):168-79</Citation><ArticleIdList><ArticleId IdType="pubmed">19086914</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 1994 Oct;84(10):1666-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7943493</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009;339:b2840</Citation><ArticleIdList><ArticleId IdType="pubmed">19602714</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2012 Jan;6(1):37-43</Citation><ArticleIdList><ArticleId IdType="pubmed">21668663</ArticleId></ArticleIdList></Reference><Reference><Citation>Braz J Infect Dis. 2013 Jan-Feb;17(1):62-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23287541</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Cell Biol. 2010 Aug;88(4):589-93</Citation><ArticleIdList><ArticleId IdType="pubmed">20651829</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 1996 Jan;49(1):51-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8598511</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2010 Jul;4(4):235-43</Citation><ArticleIdList><ArticleId IdType="pubmed">20836798</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2013 Nov;7(6):1017-32</Citation><ArticleIdList><ArticleId IdType="pubmed">23210504</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(7):e41435</Citation><ArticleIdList><ArticleId IdType="pubmed">22859985</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2009 Dec;47(12):3805-13</Citation><ArticleIdList><ArticleId IdType="pubmed">19794033</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Infect. 2009 Apr;137(4):473-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18789176</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Med. 2000;51:407-21</Citation><ArticleIdList><ArticleId IdType="pubmed">10774473</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009;338:b2137</Citation><ArticleIdList><ArticleId IdType="pubmed">19531550</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Mar 27;422(6930):428-33</Citation><ArticleIdList><ArticleId IdType="pubmed">12660783</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Oct 19;29(45):7975-81</Citation><ArticleIdList><ArticleId IdType="pubmed">21884747</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Gastroenterol. 2009 Dec;104(12):3015-23</Citation><ArticleIdList><ArticleId IdType="pubmed">19809413</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2010 Oct 5;182(14):1522-4</Citation><ArticleIdList><ArticleId IdType="pubmed">20823167</ArticleId></ArticleIdList></Reference><Reference><Citation>J Antimicrob Chemother. 1999 Nov;44 Suppl B:3-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10877456</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Care. 1997 Sep;35(9):932-47</Citation><ArticleIdList><ArticleId IdType="pubmed">9298082</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Public Health. 2011 Jul-Aug;102(4):294-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21913587</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011;342:c7297</Citation><ArticleIdList><ArticleId IdType="pubmed">21292718</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2001 Apr;46(3):264-72</Citation><ArticleIdList><ArticleId IdType="pubmed">11320681</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 1999 Jan;52(1):39-47</Citation><ArticleIdList><ArticleId IdType="pubmed">9973072</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Care. 1993 Mar;31(3):201-12</Citation><ArticleIdList><ArticleId IdType="pubmed">8450678</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Infect Dis Med Microbiol. 2012 Summer;23(2):65-70</Citation><ArticleIdList><ArticleId IdType="pubmed">23730311</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Care. 2002 Aug;40(8):675-85</Citation><ArticleIdList><ArticleId IdType="pubmed">12187181</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Nov 22;362(9397):1733-45</Citation><ArticleIdList><ArticleId IdType="pubmed">14643124</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2014 Sep 1;59(5):651-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24842908</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Infect. 2007 Oct;135(7):1109-16</Citation><ArticleIdList><ArticleId IdType="pubmed">17306052</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2012 May;18(5):801-10</Citation><ArticleIdList><ArticleId IdType="pubmed">22516189</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2003 Jan 8;289(2):179-86</Citation><ArticleIdList><ArticleId IdType="pubmed">12517228</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2000 May 12;288(5468):1051-3</Citation><ArticleIdList><ArticleId IdType="pubmed">10807575</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2008 Aug 2;372(9636):398-405</Citation><ArticleIdList><ArticleId IdType="pubmed">18675690</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2013 Sep;7(5):729-37</Citation><ArticleIdList><ArticleId IdType="pubmed">23078073</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2012 Jan;8(1):81-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22252006</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Feb 25;28(9):2149-56</Citation><ArticleIdList><ArticleId IdType="pubmed">20003926</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect. 2011 May;62(5):379-87</Citation><ArticleIdList><ArticleId IdType="pubmed">21414357</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country><region><li>Manitoba</li></region><settlement><li>Winnipeg</li></settlement><orgName><li>Université du Manitoba</li></orgName></list><tree><country name="Canada"><region name="Manitoba"><name sortKey="Hinds, Aynslie M" sort="Hinds, Aynslie M" uniqKey="Hinds A" first="Aynslie M" last="Hinds">Aynslie M. Hinds</name></region><name sortKey="Bozat Emre, Songul" sort="Bozat Emre, Songul" uniqKey="Bozat Emre S" first="Songul" last="Bozat-Emre">Songul Bozat-Emre</name><name sortKey="Mahmud, Salaheddin M" sort="Mahmud, Salaheddin M" uniqKey="Mahmud S" first="Salaheddin M" last="Mahmud">Salaheddin M. Mahmud</name><name sortKey="Mahmud, Salaheddin M" sort="Mahmud, Salaheddin M" uniqKey="Mahmud S" first="Salaheddin M" last="Mahmud">Salaheddin M. Mahmud</name><name sortKey="Van Caeseele, Paul" sort="Van Caeseele, Paul" uniqKey="Van Caeseele P" first="Paul" last="Van Caeseele">Paul Van Caeseele</name><name sortKey="Van Caeseele, Paul" sort="Van Caeseele, Paul" uniqKey="Van Caeseele P" first="Paul" last="Van Caeseele">Paul Van Caeseele</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeCanadaV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000238 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000238 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeCanadaV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25633280
|texte= Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25633280" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV4
| This area was generated with Dilib version V0.6.35. |  |